Thus, in MMD, IL-6 may induce an exacerbation of the pre-operative ischemic state by promoting thrombosis as well as amplifying inflammation and impeding revascularization following bypass surgery, leading to a poorer functional outcome. This evidence concerns the gene IL6 and multiminicore myopathy.